Advertisements



Theravance Biopharma, Mylan report "positive" data from YUPELRI studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Theravance Biopharma, Mylan report data from Phase 3 studies of YUPELRI

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2018

Theravance, Mylan Report Positive Data on COPD Drug Yupelri

Zacks.....»»

Category: topSource: redinewsSep 19th, 2018

Theravance, Mylan Report Positive Data on COPD Drug Yupelri

Theravance (TBPH) and partner Mylan post .....»»

Category: dealsSource: nytSep 18th, 2018

Theravance Biopharma reports "positive" data from multiple studies of VIBATIV

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2018

Theravance Biopharma reports "positive" data from Phase 2 trial of TD-9855

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Pluristem, Fukushima University report "positive" data from PLX-R18 studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2018

Novartis Reports Positive Long-Term Data From Cosentyx Trials

Novartis (NVS) announces encouraging five-year data from late-stage studies on Cosentyx for psoriatic arthritis and ankylosing spondylitis indications. Novartis NVS reported encouraging five-year data from ongoing extensions of the .....»»

Category: smallbizSource: nytOct 18th, 2018

AmpliPhi reports "positive" data from studies of AB-SA01

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2018

Theravance Biopharma receives positive CHMP opinion for use of Trelegy Ellipta

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 24th, 2018

Your Daily Scoop: Unum"s Positive Data, Theravance"s Treatment Benefit, Collectar"s New Designation

Your Daily Scoop: Unum"s Positive Data, Theravance"s Treatment Benefit, Collectar"s New Designation.....»»

Category: topSource: seekingalphaSep 21st, 2018

Your Daily Pharma Scoop: Theravance Positive, Denali Encouraging, Redhill Clarifies Data

Your Daily Pharma Scoop: Theravance Positive, Denali Encouraging, Redhill Clarifies Data.....»»

Category: topSource: seekingalphaAug 3rd, 2018

Cytokinetics Downgraded On Data Delay

Biopharma Cytokinetics Inc. (NASDAQ: CYTK) announced a delay in drug studies during its earnings call Thursday, prompting a downgrade by Morgan Stanley.  Latest Ratings for CYTK DateFirmAction.....»»

Category: blogSource: benzingaAug 1st, 2018

MannKind presents positive Afrezza clinical data from STAT, AFFINITY studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2018

ObsEva positive EDELWEISS data de-risks Phase 3 studies, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

Merck Presents Positive Melanoma Data on Keytruda at ASCO

Merck (MRK) presents encouraging data from two pivotal advanced melanoma studies on its PD-L1 inhibitor, Keytruda. Merck & Co., .....»»

Category: personnelSource: nytJun 5th, 2018

Roche (RHHBY) Announces Positive Data on Hemophilia Drug

Roche (RHHBY) announces positive data from two phase III studies on hemophilia drug Hemlibra which has further strengthened its hemophilia portfolio. Roche RHHBY announced full results from the phase III study, HAVEN 3, evaluating haemo.....»»

Category: dealsSource: nytMay 21st, 2018

ResMed Releases Positive U.S. & U.K. Study Data on COPD

ResMed (RMD) presents the company-sponsored health economic studies, Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV), at the ATS 2018 International Conference. ResMed Inc. RMD recently demonstrated a favorable outcome from two .....»»

Category: dealsSource: nytMay 21st, 2018

Stocks set for a slightly positive open as jobs report, trade talks dominate

U.S. stock index futures fluctuated ahead of Friday’s open, as investors awaited the latest U.S. nonfarm payrolls data......»»

Category: dealsSource: nytMay 4th, 2018

AzurRx BioPharma announces "positive" preclincal data for AZX1103

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 18th, 2018

Alnylam (ALNY) Reports Positive Data for RNAi Candidate

Alnylam (ALNY) announced encouraging results from phase I and phase I/II open-label extension studies of givosiran, which is being evaluated for the treatment of a.....»»

Category: worldSource: nytApr 17th, 2018